Drug intelligence / Profile preview

alpha-synuclein

Development stage
Preclinical
Modality
Vaccines & Immunotherapeutics
Administration
Intranasal, Intravenous, Oral, Intraperitoneal, Intracerebral, Intracisternal
01

Overview

Alpha-synuclein is a protein that is the primary component of Lewy bodies, pathological aggregates found in neurodegenerative diseases known as synucleinopathies, including Parkinson's disease, Dementia with Lewy bodies, and Multiple System Atrophy. In the context of drug development, alpha-synuclein is being investigated as an antigen in active immunization strategies (vaccines) to stimulate the body's immune system to clear or prevent the accumulation of pathological alpha-synuclein. These vaccination approaches aim to induce both humoral (antibody) and cellular (T-cell) immune responses against alpha-synuclein, thereby reducing its accumulation, neuroinflammation, and neurodegeneration.

Other names
α-synucleinα-syn
02

Targets

SNCA (Alpha-synuclein)

Beyond the preview

Go deeper on alpha-synuclein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-synuclein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call